Ultragenyx Pharmaceutical Inc. Profile Avatar - Palmy Investing

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…
Biotechnology
US, Novato [HQ]
Strategy & Leadership

Executives & BofD Beta

Total Compensation ($)

Scope

Executives

Yet No Data For Executives

Directors

Yet No Data For Directors

C-Suite and VPs/SVPs

Yet No Data For Executives

Board of Directors (BofD)

Yet No Data For Directors

End of RARE's Analysis
CIK: 1515673 CUSIP: 90400D108 ISIN: US90400D1081 LEI: - UEI: -
Secondary Listings
RARE has no secondary listings inside our databases.